| 臺大學術典藏 |
2022-09-15T03:00:13Z |
Validation of clinical frailty scale in Chinese translation
|
Chou Y.-C.; Tsou H.-H.; Chan D.-C.D.; Wen C.-J.; Lu F.-P.; Lin K.-P.; Wu M.-C.; YUNG-MING CHEN; Chen J.-H. |
| 臺大學術典藏 |
2022-08-19T00:20:50Z |
Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study
|
Cheng A.-L.; Chen P.-J.; Liu T.-W.; Chang C.-S.; Tien H.-F.; CHIUN HSU; Tsou H.-H.; Lin S.-J.; Wang M.-C.; Yao M.; Hwang W.-L.; Kao W.-Y.; Chiu C.-F.; Lin S.-F.; Lin J. |
| 臺大學術典藏 |
2022-08-19T00:20:43Z |
Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer
|
Chiang N.-J.; CHIUN HSU; Chen J.-S.; Tsou H.-H.; Shen Y.-Y.; Chao Y.; Chen M.-H.; Yeh T.-S.; Shan Y.-S.; Huang S.-F.; Chen L.-T. |
| 臺大學術典藏 |
2022-08-19T00:20:39Z |
Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection
|
CHIUN HSU; Taiwan Cooperative Oncology Group; Liu T.-W.; Chen P.-J.; Cheng A.-L.; Lin J.; Yuan Q.; Xia N.; Yao M.; Lin S.-J.; Chen J.-H.; Chang C.-S.; Pei S.-N.; Tsou H.-H.; Yang H.-C. |
| 臺大學術典藏 |
2022-08-19T00:20:36Z |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Cheng A.-L.; CHIUN HSU; Taiwan Cooperative Oncology Group; Chen P.-J.; Tsui C.-W.; Wu H.-Y.; Hsu Y.-T.; Chuang M.-H.; Hsiung C.A.; Liu T.-W.; Yang H.-C.; Hsiao C.-F.; Tsou H.-H. |
| 臺大學術典藏 |
2022-05-05T05:15:32Z |
The effect of preventing subclinical transmission on the containment of COVID-19: Mathematical modeling and experience in Taiwan
|
Tsou H.-H.; Cheng Y.-C.; Yuan H.-Y.; Hsu Y.-T.; Wu H.-Y.; Lee F.-J.; Hsiung C.A.; WEI J. CHEN; Sytwu H.-K.; Wu S.-I.; Shih S.-M.; Wen T.-H.; Kuo S.-C. |
| 臺大學術典藏 |
2022-05-05T05:15:30Z |
Nonpolio enterovirus activity during the COVID-19 Pandemic, Taiwan, 2020
|
Kuo S.-C.; Tsou H.-H.; Wu H.-Y.; Hsu Y.-T.; Lee F.-J.; Shih S.-M.; Hsiung C.A.; WEI J. CHEN |
| 臺大學術典藏 |
2022-03-08T03:44:01Z |
Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study
|
Chiang N.-J.; Chen M.-H.; SHIH-HUNG YANG; Hsu C.; Yen C.-J.; Tsou H.-H.; Su Y.-Y.; Chen J.-S.; Shan Y.-S.; Chen L.-T. |
| 國立成功大學 |
2022 |
A prospective phase II study of biweekly S-1, leucovorin, and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma – The Taiwan Cooperative Oncology Group T1217 study
|
Bai, L.-Y.;Li, C.-P.;Shan, Y.-S.;Chuang, S.-C.;Chen, J.-S.;Chiang, N.-J.;Chen, Y.-Y.;Tsou, H.-H.;Chuang, M.-H.;Chiu, Chiu C.-F.;Liu, T.-W.;Chen, L.-T. |
| 臺大學術典藏 |
2021-12-02T05:19:49Z |
Integrated care for geriatric frailty and sarcopenia: a randomized control trial
|
Chan D.-C.D.; Tsou H.-H.; CHIRN-BIN CHANG; Yang R.-S.; Tsauo J.-Y.; Chen C.-Y.; Hsiao C.-F.; Hsu Y.-T.; Chen C.-H.; Chang S.-F.; Hsiung C.A.; Kuo K.N. |
